4Beasley R, Weatherall M, Shirteliffe P, et al. Combination cortieosteroid /[B - agonist inhaler as reliever therapy: a solution for intermittent and m ld asthma? [J]. J Allergy Clin Immunol,2014,133(1) :39 -41.
5Demoly P, Gueron B, Annunziata K, et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev, 2010, 19(116):150-157.
6Kroegel C. Global Initiative for Asthma Management and Prevention-GINA 2006. Pneumologie, 2007, 61(5):295-304.
7Pedersen S. From asthma severity to control: a shift in clinical practice. Prim Care Respir J, 2010, 19(1):3-9.
8Pedersen SE, Bateman ED, Bousquet J, et al. Determinants of response to fluticasone propionate and salmeterol/flutieasone propionate combination in the Gaining Optimal Asthma control study. J Allergy Clin Immunol, 2007, 120(120):1036-1042.
9Demoly P, Annunziata K, Gubba E, et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev, 2012, 21(123):66-74.
10Janssens T, Verleden G, Van den Bergh O. Symptoms, lung function, and perception of asthma control: an exploration into the heterogeneity of the asthma control construct. J Asthma, 2012, 49(1):63-69.
